Who is sponsoring NCT04731766?

NCT04731766 is sponsored by Nayera Hassanien Mohamed.

What drugs are being tested in NCT04731766?

Interventions in NCT04731766: Citrine 5 % sodium fluoride, concocted nano-silver fluoride.

What condition does NCT04731766 study?

NCT04731766 studies Dentin Hypersensitivity.

Is NCT04731766 still recruiting?

NCT04731766 is currently status unknown. Last updated 1 February 2021.

Last reviewed 2021-02-01 · How we verify

NCT04731766

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Using Different Varnishes on Dentin Hypersensitivity; Na Fluoride and Nano-silver Fluoride

Status unknown NA Last updated 1 February 2021

What this trial tests

NA trial testing Citrine 5 % sodium fluoride in Dentin Hypersensitivity in 42 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
1 January 2022

1 January 2022

Quick facts

Lead sponsor	Nayera Hassanien Mohamed
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	42
Start date	1 November 2021
Primary completion	1 January 2022
Estimated completion	1 January 2022

Drugs / interventions tested

Citrine 5 % sodium fluoride
concocted nano-silver fluoride

Conditions studied

Dentin Hypersensitivity — all drugs for Dentin Hypersensitivity →

Sponsor

Nayera Hassanien Mohamed

Who can join

Adults 25 to 50, any sex, with Dentin Hypersensitivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

2 different varnishes will be used to test their effectiveness in controlling teeth hypersensitivity in adult patient.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Plant Extract-Synthesized Silver Nanoparticles for Application in Dental Therapy.
Ahmed O, Sibuyi NRS, Fadaka AO, Madiehe MA, et al · · 2022 · cited 41× · PMID 35214112 · DOI 10.3390/pharmaceutics14020380

Verify or expand the search:

Other recruiting trials for Dentin Hypersensitivity

Currently open trials in the same condition.

NCT07431736 — Laser Therapy for Dentin Hypersensitivity · NA · active not recruiting
NCT07069127 — Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients · NA · recruiting
NCT07113847 — Effectiveness of Resin-Based Desensitizer and Laser, Compared to Fluoride Varnish in Management of Dentine Hypersensitiv · Phase 2, PHASE3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04731766 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nayera Hassanien Mohamed
Last refreshed: 1 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04731766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing